🇺🇸 FDA
Pipeline program

rhPTH (1-84)

SHP634-401

Approved mab completed

Quick answer

rhPTH (1-84) for Hypoparathyroidism is a Approved program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 3 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Hypoparathyroidism
Phase
Approved
Modality
mab
Status
completed

Clinical trials